Tango Therapeutics TNGX Accrued interest
Accrued interest at other companies
Other financials
Where this comes from
Reported directly by Tango Therapeutics in its filing.
Tagged under the XBRL concept us-gaap:DebtSecuritiesAvailableForSaleAccruedInterestAfterAllowanceForCreditLoss.
The official record: Tango Therapeutics’s 10-Q, filed May 13, 2026, on SEC EDGAR. View the filing →
Ask your AI about Tango Therapeutics's accrued interest.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Tango Therapeutics's accrued interest?
- Tango Therapeutics (TNGX) reported accrued interest of $1.2M in Q1 2026.
- How has Tango Therapeutics's accrued interest changed year-over-year?
- Tango Therapeutics's accrued interest increased by 33.3% year-over-year, from $900K to $1.2M.
- What is the long-term trend for Tango Therapeutics's accrued interest?
- Over 3 years (2022 to 2025), Tango Therapeutics's accrued interest has grown at a 26.0% compound annual growth rate (CAGR), from $500K to $1M.
- What does accrued interest mean?
- Interest expense accrued but not yet paid on outstanding debt obligations, based on contractual interest rates and time elapsed.